Corticosteroids are among the most widely prescribed class of medicines in India used to manage everything from acute allergic reactions to chronic autoimmune diseases. Among them, Deflazacort has carved out a unique and important position, especially in the treatment of Duchenne Muscular Dystrophy (DMD), one of the most severe forms of progressive muscular weakness affecting young children.
Unlike older corticosteroids such as Prednisolone or Dexamethasone, Deflazacort offers a better side effect profile particularly with regard to weight gain and bone density loss making it a preferred long-term option for both children and adults.
With the Indian pharmaceutical market expanding rapidly and hundreds of tablets now available, choosing the right Deflazacort product can be difficult for patients, caregivers, and healthcare professionals alike. This comprehensive guide covers:
- What Deflazacort is and how it works
- Therapeutic uses and indications
- How Deflazacort compares to Prednisolone
- The best Deflazacort tablets in India with detailed profiles
- Dosage, side effects, and precautions
- FAQs
Key Pharmacological Profile
| Property | Detail |
| Drug Class | Synthetic Corticosteroid (Glucocorticoid) |
| Type | Prodrug (converted to active metabolite in body) |
| Relative Potency | ~1.2x more potent than Prednisolone (mg for mg) |
| Anti-inflammatory Action | Moderate to strong |
| Mineralocorticoid Activity | Very low (less fluid retention vs. Prednisolone) |
| Weight Gain Risk | Lower than Prednisolone |
| Bone Loss Risk | Lower than other corticosteroids |
| Available Strengths | 1mg, 6mg, 12mg, 18mg, 24mg, 30mg |
| Route of Administration | Oral (Tablet) |
Medical Uses of Deflazacort in India
Deflazacort is prescribed across multiple specialties in India:
- Duchenne Muscular Dystrophy (DMD) The most significant use Deflazacort is one of only two medications (along with corticosteroids) approved internationally for slowing the progression of DMD. It helps preserve muscle function and extend independent mobility in affected children.
- Rheumatoid Arthritis and Other Autoimmune Disorders Used to manage joint inflammation, swelling, and pain in rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus (SLE).
- Inflammatory Conditions Prescribed for asthma exacerbations, allergic conditions, inflammatory bowel disease (Crohn's disease, ulcerative colitis), and polymyalgia rheumatica.
- Nephrotic Syndrome Widely used in paediatric nephrology to manage steroid-sensitive nephrotic syndrome.
- Dermatological Conditions Used for severe eczema, pemphigus, bullous pemphigoid, and other steroid-responsive skin conditions.
- Post-Transplant Immunosuppression Used as part of immunosuppressive regimens following organ transplants to prevent rejection.
List of the Best Deflazacort Tablets in India
Here is a list of India's leading Deflazacort tablets that are manufactured by trusted companies like QNdQ derma and are produced in WHO GMP facilities to ensure maximum safety and quality measures
Uzicort 12
Uzicort 12 is a leading Deflazacort tablet in India, manufactured by QndQ Dermacare, a specialised dermatology and immunology pharmaceutical company with a strong footprint in the Indian market. The brand is particularly well-regarded for its quality consistency and packaging standards.
Composition: Deflazacort IP 12mg
Dosage Form: Film-Coated Tablets
Packaging: Alu-Alu 10×10
Manufacturer: QndQ Dermacare
Price: Rs. 1400 per box (10×10 pack)
Certifications: WHO-GMP, ISO
Therapeutic Uses:
- Duchenne Muscular Dystrophy (DMD) slowing disease progression
- Rheumatoid arthritis and autoimmune joint disorders
- Inflammatory skin conditions (eczema, pemphigus)
- Nephrotic syndrome
- Severe asthma and allergic conditions
- Post-transplant immunosuppression support
Key Features:
- Formulated with premium quality Deflazacort IP with verified bioavailability
- Packaged in Alu-Alu 10×10 blister strips superior moisture and light protection for extended shelf life
- Manufactured in a WHO-GMP and ISO certified facility with strict batch-to-batch consistency
- Designed under supervision of experienced pharmaceutical scientists and QA/QC teams
- Available for PCD Pharma Franchise and third-party manufacturing ideal for pharma entrepreneurs
- Competitive pricing for a 12mg dosage with premium packaging
- Trusted by dermatologists, neurologists, and rheumatologists across India
Why Choose Uzicort 12: The combination of premium packaging, WHO-GMP certification, and QndQ Dermacare's expertise in dermatology/immunology formulations makes Uzicort 12 a strong choice for both clinical use and business distribution.
Defcort
Defcort is one of the most widely recognised and trusted Deflazacort tablet in India, manufactured by Macleods Pharmaceuticals Pvt Ltd one of India's top 10 pharmaceutical companies with a presence in over 100 countries.
Composition: Deflazacort 6mg / 12mg
Dosage Form: Tablets
Packaging: Strip of 10 tablets
Manufacturer: Macleods Pharmaceuticals Pvt Ltd
Price: ₹75–₹120 per strip (approx.)
Certifications: WHO-GMP, ISO
Therapeutic Uses:
- Duchenne Muscular Dystrophy long-term management in paediatric patients
- Rheumatoid arthritis, ankylosing spondylitis
- Nephrotic syndrome in children and adults
- Inflammatory bowel disease
- Systemic lupus erythematosus (SLE)
- Severe allergic and skin inflammatory conditions
Key Features:
- Manufactured by Macleods Pharmaceuticals, a globally trusted Indian pharma major with exports to over 100 countries
- Available in both 6mg and 12mg strengths for flexible dosing across different conditions and patient age groups
- WHO-GMP and ISO certified manufacturing with strict QA protocols
- Widely prescribed by neurologists, paediatricians, and rheumatologists one of the most stocked Deflazacort tablets in hospital pharmacies
- Consistent track record of proven clinical efficacy with high patient and physician satisfaction
- Affordable pricing making it accessible for long-term therapy
- Excellent bioavailability ensuring reliable systemic absorption
Why Choose Defcort: Macleods' global reputation, combined with the tablets widespread availability in hospital and retail pharmacies across India, makes Defcort one of the most dependable options for chronic steroid therapy.
Defza
Defza is another flagship Deflazacort product from Macleods Pharmaceuticals, offering an alternative dosing and packaging option under a distinct tablet identity. Defza is especially popular in neurology and paediatric practices for its consistent formulation quality.
Composition: Deflazacort 6mg / 12mg
Dosage Form: Tablets
Packaging: Strip of 10 tablets
Manufacturer: Macleods Pharmaceuticals Pvt Ltd
Price: ₹80–₹130 per strip (approx.)
Certifications: WHO-GMP, ISO
Therapeutic Uses:
- Duchenne Muscular Dystrophy first-line steroid therapy for slowing muscle degeneration
- Inflammatory and autoimmune conditions
- Nephrotic syndrome
- Organ transplant immunosuppression
- Severe asthma, allergic rhinitis, and dermatitis
- Polymyalgia rheumatica
Key Features:
- Produced by Macleods Pharmaceuticals one of India's most respected and large-scale generic manufacturers
- Complies with WHO-GMP standards and international pharmacopoeial requirements
- Available in both 6mg and 12mg strengths allowing precise dose titration as needed by physicians
- Excellent bioavailability profile ensuring consistent drug levels in patients requiring long-term steroid therapy
- Strong distribution presence across pan-India available in major retail chains, hospital pharmacies, and e-pharmacies
- Preferred by paediatric neurologists for DMD management due to consistent quality and availability
Cortimax
Cortimax is a well-established Deflazacort tablet manufactured by Intas Pharmaceuticals, one of India's top 5 pharmaceutical companies and a major global generic medicines exporter. Intas brings its extensive formulation expertise and quality standards to the Cortimax range.
Composition: Deflazacort 6mg / 12mg
Dosage Form: Tablets
Packaging: Strip of 10 tablets
Manufacturer: Intas Pharmaceuticals Ltd.
Price: ₹95–₹135 per strip (approx.)
Certifications: WHO-GMP, ISO
Therapeutic Uses:
- Rheumatoid arthritis and other inflammatory joint conditions
- Duchenne Muscular Dystrophy
- Nephrotic syndrome
- Inflammatory and autoimmune skin conditions
- Severe allergic reactions
- Immune-mediated conditions requiring steroid therapy
Key Features:
- Manufactured by Intas Pharmaceuticals, a globally recognised Indian pharma major with a presence in 85+ countries
- Available in pan-India distribution with strong coverage in urban and semi-urban markets
- Certified by WHO-GMP and ISO ensuring consistent quality, purity, and efficacy
- High bioavailability the formulation is designed for rapid and reliable systemic absorption
- Available in attractive, pharmaceutical-grade packaging of 10-tablet strips for ease of dispensing
- Trusted by rheumatologists, neurologists, and paediatricians for reliable corticosteroid therapy
- Intas's rigorous internal quality control adds an extra layer of assurance for long-term prescribers
Emcort
Emcort is a popular Deflazacort tablet from Emcure Pharmaceuticals, one of India's fastest-growing pharmaceutical companies with a global presence in over 70 countries. Emcure is particularly known for its strengths in oncology, gynaecology, and inflammatory disorders.
Composition: Deflazacort 6mg / 12mg
Dosage Form: Tablets
Packaging: Strip of 10 tablets
Manufacturer: Emcure Pharmaceuticals Ltd.
Price: ₹90–₹130 per strip (approx.)
Certifications: WHO-GMP, ISO
Therapeutic Uses:
- Duchenne Muscular Dystrophy
- Autoimmune disorders SLE, rheumatoid arthritis, vasculitis
- Inflammatory bowel disease
- Severe asthma and COPD exacerbations
- Pemphigus and other bullous skin disorders
- Polymyalgia rheumatica
Key Features:
- Manufactured by Emcure Pharmaceuticals, a fast-growing global pharma company listed on NSE/BSE and recognised for quality generics
- Available in both 6mg and 12mg strengths for versatile clinical dosing
- Approved by WHO-GMP and ISO with regular quality audits
- Known for fast and effective action on inflammation and immune-mediated conditions
- Affordable pricing makes Emcort accessible for both short-term and long-term therapy
- Wide availability across India through Emcure's established distribution network
- Consistent patient satisfaction due to low incidence of excessive weight gain compared to older corticosteroids
Decmax
Decmax is a high-quality Deflazacort tablet from Zydus Cadila (now Zydus Lifesciences), one of the most respected pharmaceutical conglomerates in India and a US FDA-approved manufacturer. Zydus brings an additional layer of credibility through its US FDA approval status a mark rarely seen in this category.
Composition: Deflazacort 6mg / 12mg
Dosage Form: Tablets
Packaging: Strip of 10 tablets
Manufacturer: Zydus Cadila (Zydus Lifesciences Ltd.)
Price: ₹85–₹125 per strip (approx.)
Certifications: WHO-GMP, US FDA
Therapeutic Uses:
- Duchenne Muscular Dystrophy Deflazacort is FDA-approved for DMD and Decmax meets that standard
- Rheumatoid arthritis and ankylosing spondylitis
- Nephrotic syndrome
- Severe asthma and allergic conditions
- Inflammatory skin conditions
- Autoimmune diseases including SLE, Crohn's disease
Key Features:
- Manufactured by Zydus Cadila, one of India's most prestigious pharmaceutical groups with US FDA approval a rare distinction in the Deflazacort category
- Dual certification: WHO-GMP + US FDA highest global manufacturing quality assurance available
- Available in both 6mg and 12mg flexible for titration in both paediatric and adult patients
- Zydus's advanced manufacturing facilities and rigorous internal QA processes ensure batch consistency and purity
- Particularly preferred by specialists managing DMD patients who require stringent drug quality standards
- Strong physician and institutional trust built over decades of quality generic manufacturing
- Widely available through Zydus's extensive pan-India distribution infrastructure
Defcicot 12
Defcicot 12 is a budget-friendly and reliable Deflazacort tablet from Leefort Healthcare, a pharmaceutical company focused on delivering quality medications at accessible price points. It is a preferred option in cost-sensitive markets across Tier 2 and Tier 3 cities in India.
Composition: Deflazacort 6mg / 12mg
Dosage Form: Tablets
Packaging: Strip of 10 tablets
Manufacturer: Leefort Healthcare
Price: ₹70–₹110 per strip (approx.)
Certifications: WHO-GMP, ISO
Therapeutic Uses:
- Inflammatory and autoimmune conditions
- Nephrotic syndrome
- Rheumatoid arthritis
- Severe allergic reactions
- Dermatological conditions requiring corticosteroid therapy
- Duchenne Muscular Dystrophy (supportive therapy)
Key Features:
- Manufactured under WHO-GMP and ISO certified conditions ensuring pharmaceutical-grade quality
- Most affordable option in this list ideal for long-term patients on fixed budgets
- Available in both 6mg and 12mg strengths for clinical flexibility
- Trusted by doctors in Tier 2 and Tier 3 cities where affordability is a key prescribing factor
- Good bioavailability ensuring effective therapeutic response
- Leefort's focus on accessibility and affordability has built strong patient loyalty across semi-urban India
Quick Comparison Table: Best Deflazacort tablets in India (2024)
| Brand | Manufacturer | Composition | Price (approx.) | Key Distinction |
| Uzicort 12 | QndQ Dermacare | Deflazacort 12mg | Rs. 1400/box | PCD franchise, premium Alu-Alu pack |
| Defcort | Macleods Pharma | Deflazacort 6/12mg | ₹75–₹120/strip | Most widely stocked, top-10 pharma |
| Defza | Macleods Pharma | Deflazacort 6/12mg | ₹80–₹130/strip | Paediatric & neurology preferred |
| Cortimax | Intas Pharma | Deflazacort 6/12mg | ₹95–₹135/strip | Pan-India, global pharma major |
| Emcort | Emcure Pharma | Deflazacort 6/12mg | ₹90–₹130/strip | Fast-growing global brand |
| Decmax | Zydus Cadila | Deflazacort 6/12mg | ₹85–₹125/strip | WHO-GMP + US FDA certified |
| Defcicot 12 | Leefort Healthcare | Deflazacort 6/12mg | ₹70–₹110/strip | Most affordable, Tier 2/3 accessible |
Deflazacort vs. Prednisolone
One of the key reasons for Deflazacort's growing popularity in India is its improved safety profile compared to the more commonly used Prednisolone.
| Parameter | Deflazacort | Prednisolone |
| Relative Potency | 1.2mg Deflazacort ≈ 1mg Prednisolone | Reference standard |
| Weight Gain | Significantly lower | Higher (common complaint) |
| Bone Mineral Density Loss | Less severe | More severe with long-term use |
| Cushingoid Features | Less frequent | More frequent |
| Blood Glucose Impact | Moderate | Moderate to high |
| Mineralocorticoid Effects | Minimal | Moderate |
| Recommended for DMD | Yes (first-line in many guidelines) | Alternative |
For long-term use particularly in children with DMD or adults with autoimmune conditions Deflazacort's reduced metabolic side effects make it a clinically superior choice.
How to Choose the Right Deflazacort Tablets in India
Dosage Requirement
Deflazacort is available in 6mg and 12mg strengths in most Indian brands. The dose is calculated by body weight (typically 0.9mg/kg/day for DMD) and your doctor will prescribe the right dosage form. Always follow medical guidance.
Indication
For DMD patients or those on long-term steroid therapy, prefer brands manufactured under stricter quality standards (US FDA or WHO-GMP certified). Decmax (Zydus), Defcort (Macleods), and Uzicort 12 (QndQ Dermacare) are strong options.
Cost and Availability
For long-term therapy, cost matters. Defcicot 12 by Leefort and Defcort by Macleods offer the most budget-friendly options. For premium quality with PCD franchise needs, Uzicort 12 is ideal.
Manufacturer Credibility
Always opt for WHO-GMP certified manufacturers. For extra assurance, Zydus Cadila's US FDA certification makes Decmax a standout choice. Macleods, Intas, and Emcure are all top-tier Indian pharma companies.
For Business and Distribution
If you're a pharma distributor or franchise partner, QndQ Dermacare's Uzicort 12 offers dedicated PCD franchise and third-party manufacturing opportunities in the dermatology/immunology segment.
Deflazacort Dosage Guidelines
Important: Always follow your doctor's prescribed dosage. The below is for informational reference only.
| Condition | Typical Dosage |
| Duchenne Muscular Dystrophy | 0.9 mg/kg/day (once daily) |
| Rheumatoid Arthritis | 6–18 mg/day depending on severity |
| Nephrotic Syndrome | 1.5–2 mg/kg/day (tapering as per response) |
| Severe Asthma (short-term) | 6–18 mg/day for 5–7 days |
| Autoimmune Skin Disorders | As prescribed based on severity |
Doses are typically taken in the morning with food to minimise gastric irritation and mimic the body's natural cortisol rhythm.
Key Precautions:
- Never stop abruptly always taper Deflazacort under medical supervision to avoid adrenal crisis
- Monitor blood sugar regularly, especially in diabetic or pre-diabetic patients
- Calcium and Vitamin D supplementation is recommended for patients on long-term Deflazacort to protect bone density
- Avoid live vaccines during Deflazacort therapy
- Pregnancy and lactation use only under strict medical supervision
- Drug interactions NSAIDs, antifungals, and certain antibiotics may interact with Deflazacort
Conclusion
Deflazacort is a clinically significant corticosteroid that plays a critical role in managing some of the most challenging conditions in Indian healthcare from Duchenne Muscular Dystrophy in children to chronic autoimmune diseases in adults. Its favourable side effect profile compared to older steroids has made it an increasingly preferred option for long-term therapy.
The best Deflazacort tablets in India featured in this guide represent the full spectrum of quality, affordability, and availability:
- For premium packaging and PCD franchise: Uzicort 12 by QndQ Dermacare
- For widest availability and physician trust: Defcort and Defza by Macleods Pharmaceuticals
- For US FDA quality assurance: Decmax by Zydus Cadila
- For pan-India coverage by a global major: Cortimax by Intas Pharmaceuticals
- For budget-conscious long-term patients: Defcicot 12 by Leefort Healthcare
Always consult your doctor or specialist before starting, changing, or stopping Deflazacort therapy. The right brand, combined with the right dose and medical supervision, ensures the best possible outcomes for patients.